Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy

Autoimmunity Reviews

Volumn 8, Issue 5, 2009, Pages 410-414

  Adamus, Grazyna ^a  

^a CASEY EYE INSTITUTE   (United States)

Author keywords

Anti retinal autoantibodies; Autoimmune retinopathy; Cancer associated retinopathy; Enolase; Recoverin

Indexed keywords

ANTIBODY; AUTOANTIBODY; CARBONATE DEHYDRATASE II; PHARMACOLOGICAL BIOMARKER; RECOVERIN; RETINA AUTOANTIBODY; TRANSDUCIN; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; CORRELATION ANALYSIS; HUMAN; IMMUNOPATHOGENESIS; NEOPLASM; PARANEOPLASTIC RETINOPATHY; RETINA DEGENERATION; RETINOPATHY; REVIEW; VISUAL IMPAIRMENT;

ANIMALS; ANTIGENS, NEOPLASM; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; BLINDNESS; CARBONIC ANHYDRASE II; HUMANS; NEOPLASMS; PARANEOPLASTIC SYNDROMES; RECOVERIN; RETINA; RETINAL DEGENERATION; RISK FACTORS; TRANSDUCIN;

EID: 61349129241     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.01.002     Document Type: Review

References (40)

1. Jacobson D.M., Thirkill C.E., and Tipping S.J. A clinical triad to diagnose paraneoplastic retinopathy. Ann Neurol 28 (1990) 162-167
2. Alexander K.R., Fishman G.A., Peachey N.S., Marchese A.L., and Tso M.O.M. "On" response defect in paraneoplastic night blindness with cutaneous malignant melanoma. Inves Ophthalmol Vis Sci 33 (1992) 477-483
3. Adamus G., Machnicki M., and Seigel G.M. Apoptotic retinal cell death induced by autoantibodies of cancer associated retinopathy. Inves Ophthalmol Vis Sci 38 (1997) 283-291
4. Polans A., Witkowska D., Haley T., Amundson D., Baizer L., and Adamus G. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci USA 92 (1995) 9176-9180
5. Bazhin A.V., Schadendorf D., Willner N., Smet C.D., Heinzelmann A., Tikhomirova N.K., et al. Photoreceptor proteins as cancer-retina antigens. Inter J Cancer 120 (2007) 1268-1276
6. Ohguro H., Odagiri H., Miyagawa Y., Ohguro I., Sasaki M., and Nakazawa M. Clinicopathological features of gastric cancer cases and aberrantly expressed recoverin. Tohoku J Exp Med 202 (2004) 213-219
7. Matsubara S., Yamaji Y., Soto M., Fujita J., and Takahara J. Expression of a photoreceptor protein, recoverin, as a cancer-associated retinopathy autoantigen in human lung cancer cell lines. Br J Cancer 74 (1996) 1419-1422
8. Shiraga S., and Adamus G. Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway. J Neuroimmunol 132 (2002) 72-82
9. Saito W., Kase S., Ohguro H., Furudate N., and Ohno S. Slowly progressive cancer-associated retinopathy. Arch Ophthalmol 125 (2007) 1431-1433
10. Keltner J.L., Thirkill C.E., and Yip P.T. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases. J Neuroophthalmol 21 (2001) 173-187
11. Fernandez Madrid F. Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis. Cancer Lett 230 (2005) 187-198
12. Szekanecz É., András C., Sándor Z., Antal-Szalmás P., Szántó J., Tamási L., et al. Malignancies and soluble tumor antigens in rheumatic diseases. Autoimmun Rev 6 (2006) 42-47
13. Racanellia V., Pretea M., Minoiaa C., Favoinoa E., and Perosa F. Rheumatic disorders as paraneoplastic syndromes. Autoimmun Rev 7 (2008) 352-358
14. Graus F., Keime-Guibert F., Rene R., Benyahia B., Ribalta T., Ascaso C., et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 124 (2001) 1138-1148
15. Dalmau J., Gultekin H.S., and Posner J.B. Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Brain Pathol 9 (1999) 275-284
16. Posner J.B. Immunology of paraneoplastic syndromes: overview. Ann N Y Acad Sci 998 (2003) 178-186
17. Lorusso L., Hart I.K., Ferrari D., Ngonga G.K., Gasparetto C., and Ricevuti G. Autonomic paraneoplastic neurological syndromes. Autoimmun Rev 6 (2007) 162-168
18. Thirkill C.E., Keltner J.L., Tyler N.K., and Roth A.M. Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy. Arch Ophthalmol 111 (1993) 931-937
19. Adamus G. In: Philippov P.P., and Koch K.W. (Eds). Neuronal Calcium Sensor Protein (2006), Nova Science Publisher, Inc., New York 181-200
20. Adamus G., Machnicki M., Elerding H., Sugden B., Blocker Y.S., and Fox D.A. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo. J Autoimmun 11 (1998) 523-533
21. Maeda T., Maeda A., Maruyama I., Ogawa K.I., Kuroki Y., Sahara H., et al. Mechanisms of photoreceptor cell death in cancer-associated retinopathy. Invest Ophthalmol Vis Sci 42 (2001) 705-712
22. Adamus G., Ren G., and Weleber R.G. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol 4 (2004) 5
23. Bazhin A.V., Savchenko M.S., Shifrina O.N., Demoura S.A., Chikina S.Y., Jaques G., et al. Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors. Lung Cancer 44 (2004) 193-198
24. Kobayashi M., Ikezoe T., Uemura Y., Ueno H., and Taguchi H. Long-term survival of a patient with small cell lung cancer associated with cancer-associated retinopathy. Lung Cancer 57 (2007) 399-403
25. Weleber R.G., Watzke R.C., Shults W.T., Trzupek K.M., Heckenlively J.R., Egan R.A., et al. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies. Am J Ophthalmol 139 (2005) 780-794
26. Ohguro H., Yokoi Y., Ohguro I., Mamiya K., Ishikawa F., Yamazaki H., et al. Clinical and immunologic aspects of cancer-associated retinopathy. Am J Ophthalmol 137 (2004) 1117-1119
27. Adamus G., Aptsiauri N., Guy J., Heckenlively J., Flannery J., and Hargrave P.A. The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clin Immunol Immunopathol 78 (1996) 120-129
28. Adamus G., Amundson D., Seigel G.M., and Machnicki M. Anti-enolase alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells. J Autoimmun 11 (1998) 671-677
29. Anekonda T., Karren L., Weleber R.G., and Adamus G. In: Tabira T., Yamamura T., and Kira J. (Eds). International Proceedings -8th International Congress of Neuroimmunology (2006), Monduzzi Editore International Proceedings Division, Medimond, Bologna, Italy 219-223
30. Adamus G., Mosgrove L., David L., and Weleber R.G. Prediction of retinal phenotype and progression based on autoantibody profile in paraneoplastic and autoimmune retinopathy. Inves Ophthalmol Vis Sci 49 (2008) 4748 E-Abstract
31. Tseng R.C., Lin R.K., Wen C.K., Tseng C., Hsu H.S., Hsu W.H., et al. Epigenetic silencing of AXIN2/betaTrCP and deregulation of p53-mediated control lead to wild-type beta-catenin nuclear accumulation in lung tumorigenesis. Oncogene 27 (2008) 4488-4496
32. Chang G.C., Liu K.J., Hsieh C.L., Hu T.S., Charoenfuprasert S., Liu H.K., et al. Identification of {alpha}-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes. Clin Cancer Res 12 (2006) 5746-5754
33. Dot C., Guigay J., and Adamus G. Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung. Am J Ophthalmol 139 (2005) 746-747
34. Chegwidden W.R., Dodgson S.J., and Spencer I.M. In: Chegwidden W.R., Carter N.D., and Edwards Y.H. (Eds). The Carbonic Anhydrases New Horizons (2000), Birkhauser Verlag Basel, Basel, Switzerland 343-363
35. Milam A.H., Saari J.C., Jacobson S.G., Lubinski W.P., Feun L.G., and Alexander K.R. Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci 34 (1993) 91-100
36. Ladewig G., Reinhold U., Thirkill C.E., Kerber A., Tilgen W., and Pfohler C. Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV. Br J Dermatol 152 (2005) 931-938
37. Potter M.J., Adamus G., Szabo S.M., Lee R., Mohaseb K., and Behn D. Autoantibodies to transducin in a patient with melanoma-associated retinopathy. Am J Ophthalmol 134 (2002) 128-130
38. Hartmann T.B., Bazhin A.V., Schadendorf D., and Eichmuller S.B. SEREX identification of new tumor antigens linked to melanoma-associated retinopathy. Int J Cancer 114 (2005) 88-93
39. Bazhin A.V., Dalke C., Willner N., Abschütz O., Wildberger H.G.H., Philippov P.P., et al. Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy. Inter J Cancer 124 (2009) 140-149
40. Pittock S.J., Kryzer T.J., and Lennon V.A. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol 56 (2004) 715-719